ŞAHİN, A. B. Et Al. 2023. Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment. ONCOLOGY LETTERS , vol.26, no.6 .

ŞAHİN, A. B., Caner, B., Ocak, B., Gulmez, A., HAMİTOĞLU, B., ÇUBUKÇU, E., ... DELİGÖNÜL, A.(2023). Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment. ONCOLOGY LETTERS , vol.26, no.6.

ŞAHİN, AHMET Et Al. "Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment," ONCOLOGY LETTERS , vol.26, no.6, 2023

ŞAHİN, AHMET B. Et Al. "Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment." ONCOLOGY LETTERS , vol.26, no.6, 2023

ŞAHİN, A. B. Et Al. (2023) . "Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment." ONCOLOGY LETTERS , vol.26, no.6.

@article{article, author={AHMET BİLGEHAN ŞAHİN Et Al. }, title={Early thrombocytopenia predicts longer time-to-treatment discontinuation in trastuzumab emtansine treatment}, journal={ONCOLOGY LETTERS}, year=2023}